In vitro capability of multi-walled carbon nanotubes modified with gonadotrophin releasing hormone on killing cancer cells

Carbon

Volumn 45, Issue 10, 2007, Pages 1921-1927

  Yu, Bo Zhang ^a   Yang, Jian She ^a   Li, Wen Xin ^a  

^a SHANGHAI INSTITUTE OF APPLIED PHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLIC ACIDS; CELLS; CHEMICAL MODIFICATION; HORMONES; ONCOLOGY; PROTEINS;

CANCER CELLS; GONADOTROPHIN;

MULTIWALLED CARBON NANOTUBES (MWCN);

EID: 34547736000     PISSN: 00086223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbon.2007.06.015     Document Type: Article

References (26)

1. Pantarotto D., Partidos C.D., Hoebeke J., Brown F., Kramer E., Briand J.P., et al. Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem Biol 10 10 (2003) 961-966
2. Kueltzo L.A., and Middaugh C.R. Nonclassical transport proteins and peptides: an alternative to classical macromolecule delivery systems. J Pharm Sci 92 9 (2003) 1754-1772
3. Savic R., Luo L., Eisenberg A., and Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300 (2003) 615-618
4. Mattson M.P., Haddon R.C., and Rao A.M. Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth. J Mol Neurosci 14 3 (2000) 175-182
5. Pantarotto D., Briand J., Prato M., and Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun 1 (2004) 16-17
6. Shi Kam N.W., Jessop T.C., Wender P.A., and Dai H. Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J Am Chem Soc 126 22 (2004) 6850-6851
7. Reubi J.C. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocrine Rev 24 4 (2003) 389-427
8. Nagy A., and Schally A.V. Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers. Bio Reproduc 73 (2005) 851-859
9. Nagy A., and Schally A.V. Cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH): a new approach to targeted chemotherapy. Drugs Future 27 4 (2002) 359-370
10. Gründker C., Völker P., Griesinger F., Ramaswamy A., Nagy A., Schally A.V., et al. Antitumor effects of the cytotoxic LHRH analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice. Am J Obstet Gynecol 187 3 (2002) 528-537
11. Leuschner C., Enright F.M., Gawronska-Kozak B., and Hansel W. Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone-releasing hormone receptors. Prostate 56 4 (2003) 239-249
12. Qi L., Nett T.M., Allen M.C., Sha X., Harrison G.S., Frederick B.A., et al. Binding and cytotoxicity of conjugated and recombinant fusion proteins targeted to the gonadotropin-releasing hormone receptor. Cancer Res 64 6 (2004) 2090-2095
13. Nagy A., and Schally A.V. Targeting cytotoxic conjugates of somatostatin, luteinizing hormone-releasing hormone and bombesin to cancers expressing their receptors: a "smarter" chemotherapy. Curr Pharm Design 11 9 (2005) 1167-1180
14. Schally A.V., and Nagy A. New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin. Life Sci 72 21 (2003) 2305-2320
15. Schally A.V., and Nagy A. Chemotherapy targeted to cancers through tumoral hormone receptors. Trends Endocrinol Metab 15 7 (2004) 300-310
16. Schally A.V., and Nagy A. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors. Eur J Endocrinol 141 1 (1999) 1-14
17. Nagy A., Schally A.V., Armatis P., Szepeshazi K., Halmos G., Kovacs M., et al. Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent. Proc Natl Acad Sci USA 93 14 (1996) 7269-7273
18. Liu J., Rinzler A.G., Dai H., Hafner J.H., Bradley R.K., Boul P.J., et al. Fullerene pipes Sci 280 (1998) 1253-1256
19. Sano M., Kamino A., Okamura J., and Shinkai S. Ring closure of carbon nanotubes. Science 293 (2001) 1299-1301
20. Chen J., Hammon M.A., Hu H., Chen Y.S., Rao A.M., Eklund P.C., et al. Solution properties of single-walled carbon nanotubes. Science 282 (1998) 95-98
21. Yim T.J., Liu J., Lu Y., Kane R.S., and Dordick J.S. Highly active and stable DNAzyme-carbon nanotube hybrids. J Am Chem Soc 127 35 (2005) 12200-12201
22. Chen R.J., Zhang Y., Wang D., and Dai H. Noncovalent sidewall functionalization of single-walled carbon nanotubes for protein immobilization. J Am Chem Soc 123 16 (2001) 3838-3839
23. Sainz R., Benito A.M., Marti{dotless}́nez M.T., Galindo J.F., Sotres J., Baró A.M., et al. Soluble self-aligned carbon nanotube/polyaniline composites. Adv Mater 17 3 (2005) 278-281
24. Georgakilas V., Voulgaris D., Vazquez E., Prato M., Guldi D.M., Kukovecz A., et al. Purification of HiPCO carbon nanotubes via organic functionalization. J Am Chem Soc 124 48 (2002) 14318-14319
25. Silverstein S.C., Steinman R.M., and Cohn Z.A. Endocytosis. Annu Rev Biochem. 46 (1997) 669-722
26. Vida T.A., and Emr S.D. A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast. J Cell Biol 128 5 (1995) 779-792